Lycopene improves on basic hematological and immunological parameters in diabetes mellitus

BMC Res Notes. 2019 Dec 12;12(1):805. doi: 10.1186/s13104-019-4841-8.

Abstract

Objective: Diabetes is associated with an upset of hematological and immunological parameters in humans, however information on the effects of Lycopene is scarce. The aim of the study was to gain information on basic changes in hematological parameters as markers for safety since anemia as a complication in diabetic chemotherapy has been reported.

Results: Lycopene had anti-anemic effects and improved on the immune status of diabetic rats and these observations were dose independent. There was a decrease in neutrophil, low neutrophil-lymphocyte ratio and platelet counts and stable albumin, globulin levels. Lycopene could exert its protective effects through a balance of basic hematological physiological variables.

Keywords: Anemia; Antioxidants; Blood; Carotenoids; Diabetes.

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / immunology
  • Erythrocyte Count
  • Hemoglobins / metabolism
  • Leukocyte Count
  • Lycopene / therapeutic use*
  • Lymphocytes / drug effects
  • Male
  • Neutrophils / drug effects
  • Rats
  • Rats, Wistar

Substances

  • Antioxidants
  • Hemoglobins
  • Lycopene